Browse By Viral Diseases

This page shows data for Ebola disease.
Total Entries Retrieved: 8
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10084 ERVEBO Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Live-attenuated Approved Merck & Co. Inc. 2019 USA 18 years and above Single dose Intramuscular NA Zaire Ebola virus glycoprotein NA US FDA, EMA NA NA V920, rVSV-G-ZEBOV-GP, rVSV-ZEBOV NA NA https://www.cdc.gov/vhf/ebola/clinicians/vaccine/index.html https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2817%2930313-4/fulltext
10085 Ad26.ZEBOV Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Approved Janssen Pharmaceutical 2020 USA 1 year and above Single dose of Zabdeno on day 0 followed by 0.5mL dose of Mvabea post 8 week Intramuscular NA Adenovirus type 26 encoding the Zaire ebolavirus, Mayinga variant glycoprotein NA US FDA, EMA NA NA MVA-BN-Filo NA NCT02509494 https://clinicaltrials.gov/ct2/show/NCT02509494 https://clinicaltrials.gov/ct2/show/NCT05284097
10200 Ad5-EBOV Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Non-replicating viral vector Phase 1 National Institute of Health 2010 USA 18 - 50 years NA Intramuscular NA Ebola virus envelope glycoprotein NA NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT00374309 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ https://www.precisionvaccinations.com/vaccines/ad5-ebov-ebola-vaccine#:~:text=CanSinBio%20Ad5%2DEBOV%20is%20an,type%2D5%20vector%20immune%20response.
10201 DNA Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA DNA based vaccine Phase 1 National Institute of Health 2003 USA 18 - 44 years NA NA NA NA NA NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT00072605 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10202 rVSV-EBOV Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Phase 1 Merck & Co. Inc. 2014 USA 18 - 65 years NA Intramuscular NA Zaire Ebola virus glycoprotein Vesicular Stomatitis Virus based NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT02280408 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10203 Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO)/ChAd3-EBO-Z Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Phase 1 National Institute of Allergy and Infectious Diseases 2014 USA 18 - 65 years NA Intramuscular NA Wild type glycoproteins from Zaire and Sudan strains of Ebolavirus Chimpanzee Adenovirus Vector expressing Zaire and sudan strain glycoprotein NA NA NA NA 27764560 NCT02231866 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10204 HPIV3-EBO-Z ( HPIV3-EbovZ GP Vaccine) Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Virus like particle Phase 1 Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health 2015 USA 18 - 50 years NA Intranasal NA Zaire Ebola virus glycoprotein Live-attenuated human Parainfluenza virus type 3 vectored vaccine expressing Ebolavirus Zaire glycoprotein NA National Institute of Allergy and Infectious Diseases NA NA 27764560 NCT02564575 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA
10294 cAd3-EBO Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Recombinant viral vector Phase 2 Centre Hospitalier Universitaire Vaudois 2014 Switzerland 18 - 65 years NA Intramuscular NA Zaire Ebola virus glycoprotein Chimpanzee Adenovirus Vector expressing Zaire strain glycoprotein NA NA NA NA 27764560 NCT02289027 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287303/ NA